You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Everolimus with exemestane for treating advanced breast cancer after endocrine therapy

  • Technology appraisal guidance
  • Reference number: TA421
  • Published:  21 December 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance: 1

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 233 KB)

    Published:
    23 January 2017

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 339 KB)

    Published:
    11 November 2016
  • Committee papers (PDF 726 KB)

    Published:
    11 November 2016

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (PDF 325 KB)

    Published:
    18 August 2016
  • Committee papers (PDF 2.16 MB)

    Published:
    19 August 2016
Back to top